Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Lymphoma 13 Precursor Cell Lymphoblastic Leukemia-Lymphoma 12 Prostatic Neoplasms 11 Lymphoma, Large B-Cell, Diffuse 9 Lymphoma, Follicular 8 Leukemia 8 Lymphoma, Non-Hodgkin 7 Burkitt Lymphoma 5 Hodgkin Disease 4 Neoplasm Metastasis 3 Lymphoma, Large-Cell, Immunoblastic 3 Leukemia, Biphenotypic, Acute 3 Dendritic Cell Sarcoma, Interdigitating 3 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 2 Neoplasms 2 Multiple Myeloma 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Urogenital Neoplasms 1 Thymoma 1 Recurrence 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Neurotoxicity Syndromes 1 Neoplasms, Plasma Cell 1 Myasthenia Gravis 1 Metastatic Castration-resistant Prostate Cancer 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, B-Cell, Marginal Zone 1 Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 1

Interventions

Prednisolone 1 BID protein, human 1 Androgen Antagonists 1 Abiraterone Acetate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Abiraterone Acetate × Prednisolone × Clear all

NCT06768255 2025-01-10

mCRPC

Fudan University

Phase 3 Not yet recruiting

Abiraterone Acetate

Data powered by HemOnc (CC BY 4.0) Colophon ⚡